Literature DB >> 10347889

Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays.

M Galvin1, C Hill, R P Ross.   

Abstract

Lacticin 3147 is a broad-spectrum bacteriocin produced by Lactococcus lactis subsp. lactis DPC3147, which has been shown to be active against a range of food-borne bacteria. The reported inhibitory range for lacticin is extended to include methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, penicillin-resistant Pneumococcus, Propionibacterium acne and Streptococcus mutans. This extended host range is not obvious from traditional agar plate-based methods, but reductions in bacterial cell numbers by up to 6 log10 cfu ml-1 was observed after 2 h in time-kill curve studies conducted in broth, suggesting that the bacteriocin may have potential as a therapeutic agent in the treatment of human infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347889     DOI: 10.1046/j.1365-2672.1999.00550.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  26 in total

1.  Enhancement of the enterocin CRL35 activity by a synthetic peptide derived from the NH2-terminal sequence.

Authors:  Lucila Saavedra; Carlos Minahk; Aída P de Ruiz Holgado; Fernando Sesma
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Three Novel Lantibiotics, Ticins A1, A3, and A4, Have Extremely Stable Properties and Are Promising Food Biopreservatives.

Authors:  Bingyue Xin; Jinshui Zheng; Ziya Xu; Congzhi Li; Lifang Ruan; Donghai Peng; Ming Sun
Journal:  Appl Environ Microbiol       Date:  2015-07-31       Impact factor: 4.792

3.  Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.

Authors:  Sheila M Morgan; Paula M O'connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

Authors:  Paul D Cotter; Lorraine A Draper; Elaine M Lawton; Olivia McAuliffe; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

5.  Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

Authors:  Máire Begley; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

6.  Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI.

Authors:  Lorraine A Draper; Lucy H Deegan; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

7.  Characterization of some bacteriocins produced by lactic acid bacteria isolated from fermented foods.

Authors:  Silvia-Simona Grosu-Tudor; Mihaela-Marilena Stancu; Diana Pelinescu; Medana Zamfir
Journal:  World J Microbiol Biotechnol       Date:  2014-05-22       Impact factor: 3.312

Review 8.  Conditions of nisin production by Lactococcus lactis subsp. lactis and its main uses as a food preservative.

Authors:  Simon Khelissa; Nour-Eddine Chihib; Adem Gharsallaoui
Journal:  Arch Microbiol       Date:  2020-10-01       Impact factor: 2.552

9.  Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147.

Authors:  Paul D Cotter; Paula M O'Connor; Lorraine A Draper; Elaine M Lawton; Lucy H Deegan; Colin Hill; R Paul Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

10.  Insights into the mode of action of the two-peptide lantibiotic haloduracin.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.